Dry Powder Inhalers in London
Iconovo CEO Dr. Orest Lastow will be giving a speach at Dry Powder Inhalers Conference 27-28 July in London. The title of the speach is "How to develop…
Iconovo at RDD in Nice
Iconovo will be joining RDD Europe 2017 in Nice next week. Iconovo's participation was made possible by the kind support from the EU financed SSGG …
New employees at Iconovo
We welcome our two new associates: Richard Johnson and Fredrik Gunnarsson. Richard is a Mechanical Engineer and Fredrik is an Analytical Chemist.
Iconovo exhibiting at DDL 2016
Iconovo was a Bronze sponsor of DDL in Edinburgh. The sponsorship was in cooperation with EU financed SSGG project.
Dr Mikael Arinder joins Iconovo
Dr Mikael Arinder is Iconovo's new Vice President Operations. Mikael has a PhD. in organic chemistry and has long experience from the pharmaceutical industry…
Iconovo enters into licensing and product development with Amneal Pharmaceuticals
Iconovo has signed an agreement for a licensing deal and a product development project with Amneal Pharmaceuticals that produce and market generic drug…
Iconovo receives grant from Sweden’s innovation agency
Iconovo has received a 350 000 USD grant from Sweden’s innovation agency Vinnova. The development project includes optimization of ICOone and adaptation…
Iconovo to develop novel inhaled drug formulations together with University of Copenhagen
Iconovo has signed a development agreement with Copenhagen University. Iconovo's unit-dose inhaler ICOone will be used in two PhD projects investigating…
ICOone wins innovation award
Iconovo won the Lund University Innovation Award. The winning project was "ICOone for inhaled vaccines". Vaccines are currently administered as injections,…
ICOone in the finals to win innovation award
Iconovo is in the finals to win the Lund University Innovation Award. ICOone for inhaled vaccine was presented to the jury and judged on the level of innovation…
Connectivity in Medical Technology – Electronics in ICOone and ICOres
Iconovo CEO Dr Orest Lastow will speak at Connectivity in Medical Technology organized by Management Forum in London 24-25 June. The speach is titled "The…
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 70 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se
Press releases
Follow us on Linkedin
